Lyme Disease Antibody w/ Reflex to Blot (IgG, IgM)
Main Content
Test Code: 6646
Includes: If Lyme Disease Antibody Screen is Equivocal or Positive, Lyme Disease Antibodies (IgG, IgM), Immunoblot will be performed at an additional charge.
Methodology: Immunoassay (IA)
Clinical Significance: Lyme disease is caused by a bacterium borrelia burgdorferi and is transmitted by ticks. EIA is the screening test with high sensitivity for antibody detection. Immunoblot testing qualitatively examines with high specificity antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected EIA test result.
Alternative Name(s): Borrelia burgdorferi, Lyme Screening, Lyme Antibody Screen
Supply: T01 - Red/Gray SST 8.5mL
Preferred Specimen: Serum
Preferred Volume: 1mL
Transport Container: Serum Separator Tube (SST)
Transport Temperature: Room Temperature
Specimen Stability: Room Temperature: 7 Days
Rejection Criteria: Gross hemolysis; Gross lipemia; Plasma
For additional supply or collection device information, please contact DLO's Customer Service at (800) 891-2917, option 2.
CLIA